CIK 0001479419 · Non-accelerated filer<br>Smaller reporting company
KALA BIO, Inc.
Sign in to watch- Ticker
- KALA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 270604595
- Phone
- 781-996-5252
- Business address
- 1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
- Former names
- KALA BIO, Inc., Kala Pharmaceuticals, Inc.
- 8-K Event Results of operations
- 8-K Event Shareholder vote results
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Material agreement
- 8-K Event Director nominations · Other events
- 8-K Event Delisting notice
- 10-Q Report Quarterly Report
- NT 10-Q Other NT 10-Q
- 8-K Event Other events
- 424B5 Offering Prospectus
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- EFFECT Other Notice of Effectiveness
- S-3/A Offering Registration Statement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- S-3 Offering Registration Statement
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Other events
- 10-K Report Annual Report
Page 1 of 34 · 676 filings